Very late drug-eluting stent thrombosis in a patient with an INR of 4.4

Turk Kardiyoloji Dernegi Arsivi

Volumn 38, Issue 8, 2010, Pages 561-563

  Candemir, Başar ^a   Güleç, Sadi ^a   Özdemir, Aydan Ongun ^a   Kumbasar, Deniz ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Coronary restenosis; Coronary thrombosis etiology; Stents adverse effects; Thienopyridines; Warfarin

Indexed keywords

CLOPIDOGREL; WARFARIN;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; CASE REPORT; CATHETERIZATION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; STENT THROMBOSIS; THORAX PAIN;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959955773     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31. (Pubitemid 38067635)
2. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45:2088-92. (Pubitemid 40814135)
3. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-91. (Pubitemid 44881238)
4. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30. (Pubitemid 40617065)
5. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9. (Pubitemid 46376802)
6. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 2006;27:2784-814. (Pubitemid 44871464)
7. Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards AF, et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991;324:13-7.
8. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 1991;83:148-61.
9. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501. (Pubitemid 24256752)
10. Karjalainen PP, Vikman S, Niemelä M, Porela P, Ylitalo A, Vaittinen MA, et al. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. Eur Heart J 2008;29:1001-10. (Pubitemid 351844686)